Homology Medicines

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch FIXX and buy or sell other stocks, options, and ETFs commission-free!

About FIXX

Q32 Bio, Inc. operates as a clinical stage biotechnology company developing biologic therapeutics targeting potent regulators of the innate and adaptive immune systems to re-balance immunity in autoimmune and inflammatory diseases. It focuses on the IL-7 / TSLP receptor pathways and complement system, addressing immune dysregulation to help patients take back control of their lives. 

CEO
Jodie P. Morrison
CEOJodie P. Morrison
Employees
7
Employees7
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
Founded
Employees
7
Employees7

FIXX Key Statistics

Market cap
54.23M
Market cap54.23M
Price-Earnings ratio
-0.80
Price-Earnings ratio-0.80
Dividend yield
—
Dividend yield—
Average volume
40.36K
Average volume40.36K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$30.92
52 Week high$30.92
52 Week low
$8.24
52 Week low$8.24
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.